Intra- and Interpatient Drug Response Heterogeneity Exist in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Nongynecologic Cancers-Reference-Cited by-同舟云学术

Intra- and Interpatient Drug Response Heterogeneity Exist in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Nongynecologic Cancers

Published:2024-01-04 Issue:3 Volume:31 Page:1996-2007
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Radomski Shannon N.,Dunworth Matthew,West Junior J.,Greer Jonathan B.,Johnston Fabian M.,Ewald Andrew J.

Funder

American College of Surgeons

Commonwealth Foundation for Cancer Research Foundation

National Cancer Institute

Black in Cancer/Emerald Foundation

Johns Hopkins SPORE in Gastrointestinal Cancer

Giovanis Institute for Translational Cell Biology

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1245/s10434-023-14696-6.pdf

Reference50 articles.

1. Frassini S, Calabretto F, Granieri S, et al. Intraperitoneal chemotherapy in the management of pancreatic adenocarcinoma: a systematic review and meta-analysis. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2022;48(9):1911–21. https://doi.org/10.1016/j.ejso.2022.05.030.

2. Hughes MS, Lo WM, Beresnev T, et al. A phase II trial of cytoreduction and hyperthermic intraperitoneal chemotherapy for recurrent adrenocortical carcinoma. J Surg Res. 2018;232:383–8. https://doi.org/10.1016/j.jss.2018.06.012.

3. Rudloff U, Langan RC, Mullinax JE, et al. Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial. J Surg Oncol. 2014;110(3):275–84. https://doi.org/10.1002/jso.23633.

4. Quénet F, Elias D, Roca L, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(2):256–66. https://doi.org/10.1016/S1470-2045(20)30599-4.

5. Van Driel WJ, Koole SN, Sikorska K, et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med. 2018;378(3):230–40. https://doi.org/10.1056/NEJMoa1708618.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ASO Author Reflections: To Test or Not to Test: How Do We Decide the Optimal Site for Organoid Generation in Patients with Metastatic Disease?;Annals of Surgical Oncology;2024-01-19